Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · NCR Voyix (VYX)

NCR Voyix Q4 revenue falls to $682 million; net loss narrows to $9 million

Mixed Impact 3 of 5 earnings Written later

NCR Voyix reported fourth-quarter 2024 revenue of $682 million, down from $796 million a year earlier, while its net loss from continuing operations narrowed to $9 million from $272 million. For full-year 2025, the company expects total revenue of $2,575 million to $2,650 million, compared with $2.8 billion in 2024, and adjusted EBITDA of $420 million to $445 million.

Key points

  • Q4 2024 revenue was $682 million, versus $796 million in Q4 2023; Software & Services Revenue was $521 million, versus $530 million.
  • Q4 2024 net loss from continuing operations attributable to NCR Voyix was $9 million, versus $272 million; GAAP diluted EPS was $(0.08).
  • 2025 outlook: total revenue of $2,575 million to $2,650 million and non-GAAP diluted EPS of $0.75 to $0.80.
  • James G. Kelly was appointed President and Chief Executive Officer effective February 4, 2025.

The filing

CompanyNCR Voyix (VYX)
Form8-K, current report
Filed with the SECFeb 27, 2025, 6:47 AM ET
Accession number0000070866-25-000008

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.